Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.28B
Enterprise Value6.26B
P/E Ratio28.98
PEG Ratio0.19
Price/Sales Ratio4.67
Price/Book Ratio1.25
Enterprise/Revenue4.54
Enterprise/EBITDA22.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.16
Operating Margin0.2
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue915.12M
Revenue/Share5.52
Gross Profit822.87M
EBITDA233.49M
Net Income165.97M
Diluted EPS1.04

Balance Sheet

Total Cash799.76M
Total Cash/Share5.09
Total Debt316.76M
Total Debt/Equity0.1
Current Ratio2.58
Book Value Per Share22.18

Price History

52-Week Change-44.44
52-Week High48.44
52-Week Low24.06
Moving Average 50 Days28.63
Moving Average 200 Days33.64

Statistics

Average Volume2.7M
Shares Outstanding159.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.35
Trailing Annual Dividend Yield1.38
Payout Ratio0.46
Last Split FactorN/A
Last Split DateN/A
AD